Nexera Peptides
Retatrutide
20mg
weight management
Priority dispatch
Flat $15 — most US orders in 2–3 days
COA available
Certificate of Analysis on request
Tamper-evident seal
Verified at packaging
Discreet delivery
Plain packaging, no Nexera branding
GLP-1 + GIP + Glucagon triple agonist
20mg$200
Next-generation triple receptor agonist research peptide. Targets GLP-1, GIP, and glucagon pathways simultaneously.
Specification
Purity (HPLC)
>99%Net content
20mgVial volume
3mLLot
NXR-RET-2026
Mechanism
Triple-action: targets GLP-1, GIP, and glucagon receptors for enhanced fat loss, energy expenditure, and metabolic health research.
1
Research Use Only
This product is intended for laboratory research purposes only. Not for human consumption. Purchaser assumes all responsibility for use of the product.
Complete the protocol
Stacks well with
Compounds investigators most often study alongside Retatrutide. Every pairing links to a compound we carry and test in-house.
weight management30mL
Lipo-C (MIC)
MIC lipotropics are commonly paired with triple-agonist metabolic work.
View compound
performance wellness40mg
MOTS-c
A mitochondrial cofactor studied for energy metabolism alongside GLP-1 research.
View compound
essentials10mL
Bacteriostatic Water
Required to reconstitute the lyophilized vial.
View compound